AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

🇲🇼

NEVIRAPINE in Malawi

13 products registered with PMRA 0 active, 13 expired

Brand / ProductReg. No.HolderStatusExpires
NEVIRAPINE 50MG/5ML SUSPENSION
SUSPENSION
PMPB/PL132/87expired31 Mar 2025
NEVIMUNE 50MG/5ML SUSPENSION
SUSPENSION
PMPB/PL167/24expired31 Mar 2025
ASPEN-NEVIRAPINE*200 200MG TABLET
TABLET
PMPB/PL25/52expired31 Mar 2023
NEVIRAPINE 200MG TABLET
TABLET
PMPB/PL354/9expired30 Jun 2021
NEVIRAPINE 200MG TABLET
TABLET
PMPB/PL132/86expired30 Jun 2021
NEVIRAPINE 200MG TABLET
TABLET
PMPB/PL272/8expired30 Jun 2020
NEVIRAPINE 200MG TABLET
TABLET
PMPB/PL401/2expired30 Jun 2020
NEVIMUNE 200MG TABLET
TABLET
PMPB/PL438/6expired30 Jun 2019
NEVIRAPINE 200MG TABLET
TABLET
PMPB/PL280/28expired30 Jun 2018
NEVIMUNE 200MG TABLET
TABLET
PMPB/PL167/19expired30 Jun 2018
NEVIPAN 200MG TABLET
TABLET
PMPB/PL67/54expired30 Jun 2017
NEVIRAPINE 200MG TABLETS
TABLETS
PMPB/PL106/37expired30 Jun 2014
NEVIVIR 200MG TABLET
TABLET
PMPB/PL275/2expired30 Jun 2012

NEVIRAPINEPMRA Registration Details

PMRA (Malawi) has 13 registered products containing NEVIRAPINE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.

Track NEVIRAPINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Nevirapine — Malawi (PMRA) | AfricaRegulatory